Aviva PLC raised its holdings in shares of U.S. Physical Therapy, Inc. (NYSE:USPH – Get Rating) by 9.3% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 20,012 shares of the company’s stock after buying an additional 1,697 shares during the period. Aviva PLC owned about 0.15% of U.S. Physical Therapy worth $1,521,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also recently bought and sold shares of the business. BlackRock Inc. lifted its position in U.S. Physical Therapy by 1.1% during the first quarter. BlackRock Inc. now owns 2,076,064 shares of the company’s stock valued at $206,466,000 after buying an additional 22,653 shares in the last quarter. Vanguard Group Inc. lifted its position in shares of U.S. Physical Therapy by 1.1% during the first quarter. Vanguard Group Inc. now owns 927,480 shares of the company’s stock worth $92,238,000 after purchasing an additional 10,015 shares in the last quarter. Boston Trust Walden Corp lifted its position in shares of U.S. Physical Therapy by 12.1% during the third quarter. Boston Trust Walden Corp now owns 509,446 shares of the company’s stock worth $38,728,000 after purchasing an additional 54,956 shares in the last quarter. Eaton Vance Management lifted its position in shares of U.S. Physical Therapy by 107,124.0% during the first quarter. Eaton Vance Management now owns 491,086 shares of the company’s stock worth $48,839,000 after purchasing an additional 490,628 shares in the last quarter. Finally, State Street Corp lifted its position in shares of U.S. Physical Therapy by 0.8% during the second quarter. State Street Corp now owns 462,397 shares of the company’s stock worth $50,494,000 after purchasing an additional 3,669 shares in the last quarter. 98.44% of the stock is owned by institutional investors and hedge funds.
U.S. Physical Therapy Stock Down 1.2 %
Shares of NYSE:USPH opened at $98.75 on Friday. The company has a current ratio of 1.30, a quick ratio of 1.39 and a debt-to-equity ratio of 0.55. The company has a fifty day simple moving average of $91.78 and a 200 day simple moving average of $85.95. The firm has a market cap of $1.28 billion, a PE ratio of 43.89, a price-to-earnings-growth ratio of 3.42 and a beta of 1.33. U.S. Physical Therapy, Inc. has a 12-month low of $73.30 and a 12-month high of $131.50.
U.S. Physical Therapy Increases Dividend
Insider Buying and Selling
In related news, CFO Carey P. Hendrickson sold 550 shares of U.S. Physical Therapy stock in a transaction on Monday, December 12th. The shares were sold at an average price of $87.85, for a total value of $48,317.50. Following the completion of the sale, the chief financial officer now owns 11,607 shares in the company, valued at $1,019,674.95. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. In other U.S. Physical Therapy news, CFO Carey P. Hendrickson sold 550 shares of the business’s stock in a transaction on Monday, December 12th. The shares were sold at an average price of $87.85, for a total transaction of $48,317.50. Following the completion of the sale, the chief financial officer now owns 11,607 shares in the company, valued at $1,019,674.95. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, Director Harry S. Chapman sold 3,000 shares of the business’s stock in a transaction on Thursday, December 15th. The shares were sold at an average price of $86.00, for a total transaction of $258,000.00. Following the sale, the director now owns 10,900 shares of the company’s stock, valued at approximately $937,400. The disclosure for this sale can be found here. Over the last quarter, insiders sold 10,890 shares of company stock worth $962,916. Insiders own 1.90% of the company’s stock.
Analyst Upgrades and Downgrades
A number of research firms have recently commented on USPH. Barrington Research boosted their target price on shares of U.S. Physical Therapy from $107.00 to $110.00 and gave the stock an “outperform” rating in a research report on Friday. StockNews.com cut shares of U.S. Physical Therapy from a “hold” rating to a “sell” rating in a research report on Friday.
About U.S. Physical Therapy
U.S. Physical Therapy, Inc operates outpatient physical therapy clinics, which provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers and neurological-related injuries. It operates through the following segments: physical therapy operations and industrial injury prevention services.
See Also
- Get a free copy of the StockNews.com research report on U.S. Physical Therapy (USPH)
- MarketBeat Week in Review – 2/20 – 2/24
- Carvana Skidding On Revenue Decrease, Heavy Debt Burden
- What Are Consumer Staples Stocks?
- Is Rocky Brands Dividend A Good Fit For Your Portfolio?
- Beyond Meat Stock Is Not Beyond Hope
Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.